Clinical trial
Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
NCT00147264 · McMaster University, Other · Completed
Key facts
| NCT number | NCT00147264 |
|---|---|
| Title | Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial |
| Official title | A Randomized, Double Blind, 2X2 Factorial Design Study to Evaluate the Effects of Telmisartan vs Placebo, and of a Low-Glycemic Diet vs Control Diet, in Reducing Intra-Myocellular Lipids In Individuals With Abdominal Obesity |
| Lead sponsor | McMaster University, Other |
| Collaborators | Boehringer Ingelheim Industry Canadian Institutes of Health Research (CIHR) Heart and Stroke Foundation of Canada Medtronic |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X |
| Intervention type | Behavioral, Drug |
| Interventions | Telmisartan (Micardis®) vs. Placebo, Low-Glycemic Index Diet vs. Control Diet |
| Enrollment | 120 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 7, 2005 |
| Last update posted | Dec 14, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: